Susceptibility to verotoxin as a function of the cell cycle
- 1 March 1992
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 150 (3) , 632-639
- https://doi.org/10.1002/jcp.1041500324
Abstract
Infection with Verotoxin producing Escherichia coli (VTEC) has been implicated in hemolytic uremic syndrome, the leading cause of pediatric renal failure. Verotoxin (VT) binds to globotriaosylceramide (Galα1–4Galβ1–4GlcCer Gb3) in susceptible cells. Gb3 is required for cytotoxicity and toxin‐resistant cells deficient in Gb3 can be sensitized to VT cytotoxicity by incorporation of exogenous Gb3 into the cells. However, the absolute Gb3 content of cell lines does not necessarily correspond directly with the degree of sensitivity to VT. The present study demonstrates that susceptibility to VT is a function of cell growth and that stationary phase cells are resistant to VT. Using chemically synchronized Vero cells, we have also found a tenfold difference in susceptibility to VT during the cell cycle. Our experiments define a maximal sensitivity “window” of 1–2 hours from the G1/S boundary. This corresponds to increased VT binding without change in overall Gb3 content. Cell surface labelling indicated that cyclic turnover and exposure of Gb3 may be the critical parameter in determining VT sensitivity. Such changes during the cell cycle may also be of relevance in vivo in determining toxin pathology during VTEC infections and the physiology of plasma membrane Gb3.Keywords
This publication has 35 references indexed in Scilit:
- Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells.The Journal of cell biology, 1991
- Neutral glycosphingolipids of the globo-series characterize activation stages corresponding to germinal center B cellsInternational Immunology, 1990
- Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric diseaseInternational Immunology, 1990
- Verotoxin Receptor Glycolipid in Human Renal TissueNephron, 1989
- Monoclonal antibodies produced by immunization with neoglycoproteins containing galα1‐4galβ1‐4glcβ‐O and galα1‐4galβ1‐4glcnacβ‐O residues: Useful immunochemical and cytochemical reagents for blood group p antigens and a differentiation marker in burkitt lymphoma and other B‐cell malignanciesInternational Journal of Cancer, 1988
- PATHOGENESIS OF HAEMOLYTIC URAEMIC SYNDROMEThe Lancet, 1987
- Purification and biological properties ofEscherichia coliverocytotoxinFEMS Microbiology Letters, 1987
- Factors affecting surface expression of glycolipids: influence of lipid environment and ceramide composition on antibody recognition of cerebroside sulfate in liposomesBiochemistry, 1986
- The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coliThe Journal of Infectious Diseases, 1985
- A model of cell cycle control: Effects of thymidine on synchronous cell culturesCell, 1975